Objectives This review highlights the dual metabolic and psychological impacts of GLP-1 and GIP agonists in diabetes and obesity management, emphasizing the need for a holistic, patient-centered approach to optimize treatment outcomes
The use of supraclavicular free flap with vascularized lymph node transfer for treatment of lymphedema: a prospective study of 100 consecutive cases
Particularly if someones got type 2 diabetes, they should be having once-a-year back-of-the-eye checks and understanding whether they might have additional risk factors, including their cup-to-disc ratio. According to the Database of Adverse Event Notifications, 36 cases of optic ischaemic neuropathy with GLP-1s have been identified, including 23 for semaglutide, 10 for tirzepatide and three for liraglutide
Starting weight and metabolic health People with higher starting weights often lose more absolute weight in the early weeks, partly because their higher caloric needs create a larger deficit when appetite decreases
Shed does not offer this at the time of writing